On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Dr. James Olzmann completed his undergraduate studies in Biology at the University of Michigan and earned his Ph.D. in Neuroscience at Emory University. He then performed his postdoctoral research in the laboratory of Dr. Ron Kopito at Stanford University, where he studied the cellular mechanisms of ER protein quality control. In 2013, he established his independent research group at the University of California, Berkeley where he is the Doris H. Calloway Chair and Professor of Molecular Therapeutics. He holds a joint appointment in the Departments of Molecular & Cell Biology and Nutritional Sciences & Toxicology. Dr. Olzmann’s research group investigates the principles that regulate cellular lipid homeostasis, including the mechanisms that influence neutral lipid storage in lipid droplets and oxidative lipid damage during ferroptosis. His group further aims to develop small molecule tools and therapeutics to target these pathways in disease. Dr. Olzmann’s contributions to the field have been recognized with several honors, such as the Presidential Early Career Award for Scientists and Engineers, American Society for Cell Biology Günter Blobel Early Career Award, Chan Zuckerberg Biohub Investigator appointment, UC Berkeley Beatriz Manz Award, and Miller Institute Professorship Award.
